What's in EpiCept Corporation's pipeline?

EpiCept Corporation has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with EpiCept Corporation's portfolio?

Top competitors by shared drug class: Bayer, Express Specialty Pharmacy, Georg Kägi, MD, Grünenthal GmbH, Henry Ford Health System.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/epicept-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

EpiCept Corporation — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EpiCept Corporation pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Gabapentin Capsules	Gabapentin Capsules	marketed	Anticonvulsant; Gabapentinoid	Alpha-2-delta-1 subunit of voltage-gated calcium channels	Neurology

Therapeutic area mix

Neurology · 1
Pain management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Express Specialty Pharmacy · 1 shared drug class
Georg Kägi, MD · 1 shared drug class
Grünenthal GmbH · 1 shared drug class
Henry Ford Health System · 1 shared drug class
Johnson & Johnson Consumer and Personal Products Worldwide · 1 shared drug class
NeurogesX · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for EpiCept Corporation:

Cite this brief

Drug Landscape (2026). EpiCept Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/epicept-corporation. Accessed 2026-05-16.